Market research
603309.SHG Well Lead Medical Co., Ltd
SHG CNY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3B
- P/E ratio
- 55.45
- Analyst target
- 42.5
- Dividend yield
- 4.3%
- Beta
- -0.16
Profile
Company facts
- Exchange
- SHG
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- CNE1000021C2
- Market cap
- 3B
- P/E ratio
- 55.45
- Analyst target
- 42.5
- Dividend yield
- 4.3%
- Beta
- -0.16
About
About Well Lead Medical Co., Ltd
Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, urethral and ureteral dilation, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngeal masks, endobronchial and tracheostomy tubes, anesthesia breathing circuits and accessories, and nasopharyngeal and oropharyngeal airway products. The company also offers respiratory products, including oxygen and aerosol therapy products, and capnography mask and cannula products; drainage/suction/gastroenterology products, such as drainage systems, Yankauer handles, suction catheters, and stomach and feeding tubes; hemodialysis blood tubing set; home care products, including male external catheter and convicath intermittent catheter; and ambulatory infusion pump for pain management. Well Lead Medical Co., Ltd. was founded in 1998 and is based in Guangzhou, China.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 603309.SHG discussion.
5 years, 5 months ago
Well Lead Medical Co., Ltd is currently in a long term uptrend where the price is trading 2.6% above its 200 day moving average.
From a valuation standpoint, the stock is 69.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Well Lead Medical Co., Ltd's total revenue rose by 14.0% to $293M since the same quarter in the previous year.
Its net income has increased by 30.0% to $42M since the same quarter in the previous year.
Finally, its free cash flow grew by 58.1% to $38M since the same quarter in the previous year.
Based on the above factors, Well Lead Medical Co., Ltd gets an overall score of 5/5.